Market Cap

Protalix BioTherapeutics, Inc. Market Capitalization:

₪292.9 Million

ILS as of Jan. 1, 2023

US$83.6 Million

business Protalix BioTherapeutics, Inc. Company Profile

Protalix BioTherapeutics, Inc. Main Stock Listing

TASE: PLX

Market Capitalization History of Protalix BioTherapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Protalix BioTherapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 ₪292.9 M 119.45%
Jan. 1, 2022 ₪133.5 M -81.33%
Jan. 1, 2021 ₪715.1 M 15.95%
Jan. 1, 2020 ₪616.7 M -25.12%
Jan. 1, 2019 ₪823.7 M -31.74%
Jan. 1, 2018 ₪1.21 B 2.45%
Jan. 1, 2017 ₪1.18 B -30.83%
Jan. 1, 2016 ₪1.70 B -58.30%
Jan. 1, 2015 ₪4.08 B -45.38%
Jan. 1, 2014 ₪7.48 B -22.13%
Jan. 1, 2013 ₪9.60 B -6.38%
Jan. 1, 2012 ₪10.26 B -94.12%
Jan. 1, 2011 ₪174.37 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Protalix BioTherapeutics, Inc. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

Protalix BioTherapeutics, Inc. has the following listings and related stock indices.


Stock: TASE: PLX

Stock: NYSE: PLX

Stock: FSX: PBDA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.